Pathfinder Cell Therapy, Inc.
PFND
$0.00
$0.000.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -289.00K | -222.00K | -276.00K | -293.00K | -284.00K |
| Total Depreciation and Amortization | 1.00K | 1.00K | 1.00K | 0.00 | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 0.00 | 0.00 |
| Change in Net Operating Assets | 110.00K | 123.00K | 99.00K | 166.00K | 55.00K |
| Cash from Operations | -178.00K | -98.00K | -176.00K | -127.00K | -228.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 187.00K | 92.00K | 185.00K | 145.00K | 230.00K |
| Total Debt Repaid | -5.00K | -15.00K | -14.00K | -15.00K | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 182.00K | 77.00K | 171.00K | 130.00K | 230.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.00K | -21.00K | -5.00K | 3.00K | 2.00K |